MedPath

Retinal Function in Relation to Long Term Changes in the Glucose Level

Conditions
Diabetes Mellitus
Interventions
Other: Insulin pump
Registration Number
NCT00973401
Lead Sponsor
Glostrup University Hospital, Copenhagen
Brief Summary

The purpose of this study is to measure the amplitude and implicit time of electroretinogram (ERG), darkadaptation and the calibre of retinal vessels before and after optimized medical treatment of diabetic individuals (a lower blood glucose level) over a period of 12 months. Newly diagnosed type 1 and type 2 diabetics as well as dysregulated type 1 and type 2 diabetic individuals will be included. Retinal vessel calibre measurements will be used as an estimation of changes in the retinal perfusion.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Dysregulated type 1 diabetic individuals and newly diagnosed type 1 diabetics. Age >17 < 60 years
Exclusion Criteria
  • Test individuals with significant cataract, prior surgery to the eye, diabetic retinopathy, other serious eye disease, hypertension, other serious systemic disease.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diabetic individualsInsulin pump-
Primary Outcome Measures
NameTimeMethod
Changes in amplitude/implicit times, retinal vessel diameter, dark adaptation and OCT1 week, 1 month, 4 months, 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Glostrup Hospital

🇩🇰

Glostrup, Denmark

© Copyright 2025. All Rights Reserved by MedPath